Search results
Results from the WOW.Com Content Network
This is a list of investigational aggression drugs, or drugs that are currently under development for clinical use in the treatment of aggression but are not yet approved. Drugs used to treat aggression may also be known as "serenics". [1] Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
Intermittent explosive disorder (IED), or episodic dyscontrol syndrome (EDS), is a mental and behavioral disorder characterized by explosive outbursts of anger or violence, often to the point of rage, that are disproportionate to the situation at hand (e.g., impulsive shouting, screaming, or excessive reprimanding triggered by relatively inconsequential events).
SRX246, also known as API-246, is a small-molecule, centrally-active, highly-selective vasopressin V 1A receptor antagonist which is under investigation by Azevan Pharmaceuticals for the treatment of affective and anger disorders. [1] [2] [3] It is an azetidinone derivative, and was developed from LY-307174 as a lead compound. [4]
301.2 Schizoid personality disorder; 301.3 Explosive personality disorder (Include: aggressive: personality/reaction, aggressiveness, emotional instability (excessive), pathological emotionality, quarrelsomeness) 301.4 Anankastic personality disorder (Include: compulsive personality, obsessional personality)
List of investigational attention deficit hyperactivity disorder drugs; List of investigational autism and pervasive developmental disorder drugs; List of investigational hallucinogens and entactogens; List of investigational obsessive–compulsive disorder drugs; List of investigational sex-hormonal agents; List of investigational sexual ...
This is a list of investigational agitation drugs, or drugs that are currently under development for clinical use in the treatment of agitation, for instance in people with dementia or autism, but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.
The disinhibited externalizing spectrum includes some signs and symptoms of such disorders as alcohol use disorder, substance use disorders, ADHD, conduct disorder, antisocial personality disorder, intermittent explosive disorder, oppositional defiant disorder, and provisionally borderline personality disorder. [17]
Intermittent explosive disorder or IED is a clinical condition of experiencing recurrent aggressive episodes that are out of proportion of any given stressor. Earlier studies reported a prevalence rate between 1–2% in a clinical setting, however a study done by Coccaro and colleagues in 2004 had reported about 11.1% lifetime prevalence and 3. ...